Breakthroughs Blog

City of Hope has so many breakthroughs in cancer, diabetes and HIV/AIDS - and so many stories - that we've tailored our blog, Breakthroughs, to provide something for every reader. Whether the breakthroughs are about medical research, treatment advances or personal triumphs, they're all connected.

Monica Curiel, City of Hope patient, author
Young Lymphoma Survivor Pens Children’s Book

July 12, 2017 | Samantha Bonar

Monica Curiel was 19 years old, a freshman in college, when diagnosed. Now a survivor, her book, Stella's Picture Day, for pediatric cancer patients, was published in May 2016.

Continue Reading

patel sunita 256x256
City of Hope Researcher Receives Grant to Improve Cognitive Outcomes in Young Cancer Patients

July 7, 2017 | Samantha Bonar

Sunita Patel, Ph.D., a neuropsychologist in the Population Sciences and Supportive Care Medicine departments at City of Hope, has received a $1.22 million grant from the American Cancer Society to test a new approach toward preventing long-term chemotherapy-related cognitive side effects in childhood cancer survivors from bilingual and Spanish-speaking families.

Continue Reading

robert w chen md 256x256
Immunotherapy Drug Shown Safe and Effective in Treating Hodgkin Lymphoma

June 29, 2017 | Katie Neith

Clinical trial results in positive outcomes for patients with relapsed or treatment-resistant disease. Hodgkin lymphoma is typically considered to be one of the most curable forms of cancer, but some with the disease relapse or find that their cancer is resistant to treatment. For patients like this, a fully human monoclonal antibody called avelumab has shown promising results in a phase 1 clinical trial for safety and efficacy.

Continue Reading

Suzettes Story - The Journey Is Everything
Suzette's Story: The Journey Is Everything

June 14, 2017 | Abe Rosenberg

Suzette Hodnett is a Stage 4 cancer survivor who captivated every medical professional who operated on her, medicated her, irradiated her or rehabbed her. She is also the author of "The Journey is Everything: Saying Yes to Cancer."

Continue Reading

Christine Magnus Moore
Caregiver, Cancer Survivor and Author: City of Hope Nurse Christine Magnus Moore

June 5, 2017 | Michael Easterling

As an oncology nurse, Christine Magnus Moore, R.N., B.S.N., has cared for patients going through the most challenging circumstances one can imagine. But she didn’t fully comprehend the courage of these cancer patients until she became one herself.

Continue Reading

Mark Paolera
Immunotherapy Gives Hodgkin Lymphoma Patient a Second Chance

May 26, 2017 | Samantha Bonar

Four years ago, Mark Paolera, now 39, was busy enjoying the typical active California lifestyle, including mountain biking, hiking and deep-sea fishing. After a battery of tests, Paolera was diagnosed with Stage 2 Hodgkin lymphoma in May of 2014.

Continue Reading

breakthroughs - Campbells 256x256
From Patient to Patron: Lymphoma Survivor Pays It Forward

February 9, 2017 | Michael Easterling

Deana and Steve Campbell made a generous donation to City of Hope to establish The Deana and Steve Campbell Chief Clinical Officer’s Distinguished Chair in Honor of Alexandra Levine, M.D. The holder of the endowed Chair, yet to be recruited, will demonstrate the same level of commitment to City of Hope’s values, ideals and philosophy as Levine has personified.

Continue Reading

Herrera-Alex
City of Hope doctor tackles two difficult-to-treat lymphomas

February 1, 2017 | Letisia Marquez

Alex F. Herrera, M.D., an assistant professor in City of Hope’s Department of Hematology & Hematopoietic Cell Transplantation, and a team of doctors at City of Hope and the Dana-Farber Cancer Institute examined how well patients whose double-hit and/or double-expressor lymphoma had recurred, or was resistant to initial treatment, fared after they had received high-dose chemotherapy and underwent an autologous stem cell transplantation.

Continue Reading

Chen-Robert
Trial Results Point to Promising Treatments for Hodgkin Lymphoma Patients

January 9, 2017 | Abe Rosenberg

Everything changed when Hodgkin lymphoma patient Lowell Winer joined a Phase II clinical trial examining the effectiveness of brentuximab vedotin (BV) after a failed transplant. The BV worked immediately, achieving a complete remission which, year after year, proved to be durable beyond anyone's expectations.

Continue Reading

Load More
Back To Top